BRIMOVIB T EYE DROPBRIMONIDINE TARTRATE 0.2%w/v IP + TIMOLOL MALEATE 0.5%w/v IP + BENZALKONIUM CHLO...

Brimovib T Eye Drop is a prescription eye drop used to lower raised eye pressure in glaucoma and ocular hypertension. Main uses: reduction of raised pressure inside the eye (elevated intraocular pressure); raised eye pressure in patients with glaucoma; raised eye pressure in patients with ocular hypertension; use when pressure is not adequately controlled and an added or replacement medicine is required.

Common side effects of Brimovib T Eye Drop include allergic conjunctivitis; redness of the conjunctiva; itching of the eye; burning or stinging in the eye; conjunctival folliculosis; blurred vision. Get medical help at once if you notice bronchospasm or severe breathing difficulty, especially in patients with airway disease; slow heart rate, heart block or worsening heart failure; severe allergic reaction with swelling of the face or eyelids and skin rash.

Brimovib T Eye Drop contains Brimonidine Tartrate 0.2%w/v + Timolol Maleate 0.5%w/v + Benzalkonium Chloride 0.005%v/v. The right dose and how long to take it depend on the condition, age and other medicines, so use Brimovib T Eye Drop only as your doctor advises.

The MRP of Brimovib T Eye Drop is ₹360.94 for a pack of 5ml. For chemists and distributors, the PTR is ₹275 and the PTS is ₹247.5.

Brimovib T Eye Drop contains Brimonidine Tartrate 0.2%w/v + Timolol Maleate 0.5%w/v + Benzalkonium Chloride 0.005%v/v. It comes in a pack of 5ml.

Brimonidine Tartrate works on alpha-2 receptors in the eye to reduce fluid formation, while Timolol Maleate is a beta-blocker that also cuts down the fluid produced in the eye. Together the two active ingredients lower the pressure inside the eye. Benzalkonium Chloride is a preservative that helps limit microbial growth in the solution.

Must not be used by patients with bronchial asthma, a history of bronchial asthma or severe chronic obstructive pulmonary disease. Must not be used by patients with sinus bradycardia, second or third degree atrioventricular block, overt cardiac failure or cardiogenic shock. Must not be used in neonates and infants below 2 years of age. Must not be used by anyone with hypersensitivity to any component of these drops. Check with a doctor first if you have diabetes, thyroid disease, myasthenia gravis, poor blood circulation, low blood pressure, or if you are pregnant or breastfeeding, or wear soft contact lenses.

Brimovib T Eye Drop is a brand of Vibcare Pharma, sold through its Optho division. It is available for PCD pharma franchise and distribution in India; use the Send Enquiry or WhatsApp button on this page to ask about availability and terms.